Sonoma Pharmaceuticals Inc Share Price Nasdaq
Equities
US83558L1052
Pharmaceuticals
Sales 2024 * | 14.7M 1.23B | Sales 2025 * | 17.9M 1.49B | Capitalization | 2.48M 207M |
---|---|---|---|---|---|
Net income 2024 * | -5M -417M | Net income 2025 * | -3M -250M | EV / Sales 2024 * | 0.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
-0.18
x | P/E ratio 2025 * |
-0.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.44% |
Managers | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/19/27 |
John Poggetto
DFI | Director of Finance/CFO | 53 | 01/02/01 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 08/20/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/19/27 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 20/07/20 |
Director/Board Member | 64 | 19/18/19 |
1st Jan change | Capi. | |
---|---|---|
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |